Literature DB >> 27761987

Long-term effect of exercise on improving fatty liver and cardiovascular risk factors in obese adults: A 1-year follow-up study.

Hui-Jie Zhang1,2, Ling-Ling Pan3, Zhi-Min Ma4, Zheng Chen1, Zhu-Feng Huang1, Qian Sun1, Yan Lu5, Cheng-Kun Han1, Ming-Zhu Lin1, Xue-Jun Li1, Shu-Yu Yang1, Xiao-Ying Li5.   

Abstract

Exercise training can reduce hepatic fat accumulation and cardiovascular risk among patients with non-alcoholic fatty liver disease (NAFLD), but how long these benefits extend beyond the period of active intervention is unclear. Intrahepatic triglyceride (IHTG) content, measured by proton magnetic resonance spectroscopy, and metabolic risk factors among 220 obese people with NAFLD, who were randomly assigned to vigorous/moderate exercise, moderate exercise or no exercise (control), were assessed at 1 year after the 12-month exercise intervention. IHTG content was significantly reduced in the 2 exercise groups compared with the control group over the 12-month active intervention. It was significantly lower (by -2.39%) in the vigorous/moderate exercise group compared with the control group at the 1-year follow-up (95% confidence interval -4.72 to -0.05%; P = .045). Waist circumference and blood pressure remained significantly lower in the vigorous/moderate exercise group and the moderate exercise group compared with the control group at the 1-year follow-up. Visceral adipose fat remained significantly reduced, but with no differences among 3 groups. These findings suggest 12-month exercise intervention induced reductions in hepatic fat accumulation, abdominal obesity and blood pressure for up to 1 year after the active intervention, with some attenuation of the benefits.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  abdominal obesity; cardiovascular risk factors; exercise; intrahepatic triglyceride content; non-alcoholic fatty liver disease

Mesh:

Substances:

Year:  2016        PMID: 27761987     DOI: 10.1111/dom.12809

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  17 in total

Review 1.  Exercising the hepatobiliary-gut axis. The impact of physical activity performance.

Authors:  Emilio Molina-Molina; Raquel Lunardi Baccetto; David Q-H Wang; Ornella de Bari; Marcin Krawczyk; Piero Portincasa
Journal:  Eur J Clin Invest       Date:  2018-06-14       Impact factor: 4.686

2.  Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Andrea Gonzalez; Mayalen Valero-Breton; Camila Huerta-Salgado; Oscar Achiardi; Felipe Simon; Claudio Cabello-Verrugio
Journal:  Eur J Transl Myol       Date:  2021-03-26

Review 3.  Comparative efficacy of exercise training processes in improving nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Xue Yu; Yan Wang; Jianming Lai; Ting Song; Jianping Duan
Journal:  Ir J Med Sci       Date:  2022-04-02       Impact factor: 1.568

Review 4.  Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Authors:  Tiffany M Powell-Wiley; Paul Poirier; Lora E Burke; Jean-Pierre Després; Penny Gordon-Larsen; Carl J Lavie; Scott A Lear; Chiadi E Ndumele; Ian J Neeland; Prashanthan Sanders; Marie-Pierre St-Onge
Journal:  Circulation       Date:  2021-04-22       Impact factor: 29.690

Review 5.  Diet and exercise in NAFLD/NASH: Beyond the obvious.

Authors:  Georg Semmler; Christian Datz; Thomas Reiberger; Michael Trauner
Journal:  Liver Int       Date:  2021-08-21       Impact factor: 8.754

6.  Effect of a High Protein, Low Glycemic Index Dietary Intervention on Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial.

Authors:  Ping Sun; Liping Huang; Ping Shuai; Zhengwei Wan; Yingying Liu; Jianqiang Xue; Yuping Liu
Journal:  Front Nutr       Date:  2022-04-27

Review 7.  Exercise Prescription Intervention Rehabilitation Suggestions for Fatty Liver Patients.

Authors:  Tian Wan; Kun-Da Hong; Si-Yu Lu
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-16       Impact factor: 2.650

8.  Dose-response association between physical activity and non-alcoholic fatty liver disease: a case-control study in a Chinese population.

Authors:  YangFan Li; Fei He; Yun He; XinTing Pan; YunLi Wu; ZhiJian Hu; Xu Lin; ShangHua Xu; Xian-E Peng
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

9.  Co-administration of obeticholic acid and simvastatin protects against high-fat diet-induced non-alcoholic steatohepatitis in mice.

Authors:  Wen-Cong Li; Su-Xian Zhao; Wei-Guang Ren; Yu-Guo Zhang; Rong-Qi Wang; Ling-Bo Kong; Qing-Shan Zhang; Yue-Min Nan
Journal:  Exp Ther Med       Date:  2021-06-03       Impact factor: 2.447

10.  Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis.

Authors:  Elena Buzzetti; Audrey Linden; Lawrence Mj Best; Angela M Madden; Danielle Roberts; Thomas J G Chase; Suzanne C Freeman; Nicola J Cooper; Alex J Sutton; Dominic Fritche; Elisabeth Jane Milne; Kathy Wright; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.